Degarelix is a semi-synthetic peptide that acts as an antagonist of the gonadotropin-releasing hormone (GnRH) receptor, suppressing testosterone production and used in the treatment of prostate cancer [57]. This evidence concerns the gene GNRHR and Familial prostate cancer.